{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:29:40Z","timestamp":1763767780987,"version":"3.41.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.wneu.2024.01.006","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T04:16:15Z","timestamp":1704428175000},"page":"239-245.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Survival Impact of Combined Biguanide and Temozolomide in Glioblastoma Preclinical Models: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"183","author":[{"given":"Marcio Yuri","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elo\u00edsa Bittencurt","family":"Thomaz de Assis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savio","family":"Batista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucca B.","family":"Palavani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1043-6402","authenticated-orcid":false,"given":"Gabriel","family":"Verly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6863-8997","authenticated-orcid":false,"given":"Eduardo Mendes","family":"Corr\u00eaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0298-1052","authenticated-orcid":false,"given":"Lucas Pari","family":"Mitre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Sales de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6546-2634","authenticated-orcid":false,"given":"Raphael","family":"Bertani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Antunes","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6363-6290","authenticated-orcid":false,"given":"Allan Dias","family":"Polverini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2024.01.006_bib1","article-title":"Brain tumors: rise in glioblastoma multiforme incidence in England 1995\u20132015 suggests an adverse environmental or lifestyle factor","volume":"2018","author":"Philips","year":"2018","journal-title":"J\u00a0Environ Public Health"},{"key":"10.1016\/j.wneu.2024.01.006_bib2","doi-asserted-by":"crossref","first-page":"IV1","DOI":"10.1093\/neuonc\/noaa200","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013\u20132017","volume":"22","author":"Ostrom","year":"2020","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.01.006_bib3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jocn.2009.09.004","article-title":"Survival comparison between glioblastoma multiforme and other incurable cancers","volume":"17","author":"Tran","year":"2010","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.wneu.2024.01.006_bib4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3322\/caac.21613","article-title":"Management of glioblastoma: state of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.wneu.2024.01.006_bib5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.wneu.2017.04.035","article-title":"Prognostic implications of extent of resection in glioblastoma: analysis from a large database","volume":"103","author":"Trifiletti","year":"2017","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2024.01.006_bib6","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"12 Suppl 2","key":"10.1016\/j.wneu.2024.01.006_bib7","doi-asserted-by":"crossref","first-page":"iii1","DOI":"10.1093\/neuonc\/noab200","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014-2018","volume":"23","author":"Ostrom","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.01.006_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/ijc.31783","article-title":"Use of metformin and survival of patients with high-grade glioma","volume":"144","author":"Seliger","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.wneu.2024.01.006_bib9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12672-023-00678-3","article-title":"Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study)","volume":"14","author":"Yoon","year":"2023","journal-title":"Discov Oncol"},{"key":"10.1016\/j.wneu.2024.01.006_bib10","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.4143\/crt.2017.466","article-title":"High-dose metformin plus temozolomide shows increased anti-tumor effects in glioblastoma in\u00a0vitro and in\u00a0vivo compared with monotherapy","volume":"50","author":"Lee","year":"2018","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.wneu.2024.01.006_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.664149","article-title":"Imaging metformin efficacy as add-on therapy in cells and mouse models of human EGFR glioblastoma","volume":"11","author":"Valtorta","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.wneu.2024.01.006_bib12","doi-asserted-by":"crossref","first-page":"32930","DOI":"10.18632\/oncotarget.5405","article-title":"Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in\u00a0vitro and in\u00a0vivo","volume":"6","author":"Yu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.wneu.2024.01.006_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE's risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med Res Methodol"},{"year":"2023","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.4","key":"10.1016\/j.wneu.2024.01.006_bib14"},{"key":"10.1016\/j.wneu.2024.01.006_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.wneu.2024.01.006_bib16","doi-asserted-by":"crossref","first-page":"65643","DOI":"10.18632\/oncotarget.11595","article-title":"Inhibiting stemness and invasive properties of glioblastoma tumorsphere by combined treatment with temozolomide and a newly designed biguanide (HL156A)","volume":"7","author":"Choi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.wneu.2024.01.006_bib17","doi-asserted-by":"crossref","first-page":"56456","DOI":"10.18632\/oncotarget.10919","article-title":"Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma","volume":"7","author":"Jiang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.wneu.2024.01.006_bib18","doi-asserted-by":"crossref","first-page":"113090","DOI":"10.18632\/oncotarget.23028","article-title":"Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models","volume":"8","author":"Valtorta","year":"2017","journal-title":"Oncotarget"},{"issue":"Suppl 3","key":"10.1016\/j.wneu.2024.01.006_bib19","doi-asserted-by":"crossref","first-page":"iii69","DOI":"10.1093\/neuonc\/nox036.255","article-title":"P08.66 Concomitant treatment with metformin plus temozolomide increases the anti-tumor effects on glioblastoma in\u00a0vitro and in\u00a0vivo","volume":"19","author":"Yang","year":"2017","journal-title":"Neuro Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.wneu.2024.01.006_bib20","first-page":"1","article-title":"EP-004 evaluation of radiotherapy associated with temozolomide plus metformin in a GBM immunocompetent microenvironment European association of nuclear medicine October 20-23, 2021 virtual","volume":"48","author":"Salvatore","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.wneu.2024.01.006_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1096614","article-title":"A\u00a0combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in\u00a0vivo","volume":"14","author":"Kuduvalli","year":"2023","journal-title":"Front Pharmacol"},{"issue":"suppl_8","key":"10.1016\/j.wneu.2024.01.006_bib24","first-page":"viii3","article-title":"Factors effecting survival in patients with glioblastoma multiforme","volume":"17","author":"Henderson","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.01.006_bib25","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1080\/02688697.2019.1612145","article-title":"FM1-6 glioblastoma \u2013 our survival data and possible evidence to support a role for metformin? (2019) proceedings of the spring 2019 Joint meeting of the Society of British Neurological Surgeons and the European Association of Neuroscience Nurses","volume":"33","author":"Razak","year":"2019","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.wneu.2024.01.006_bib26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2217\/cns.13.12","article-title":"Retrospective analysis of the effects of steroid therapy and antidiabetic medication on survival in diabetic glioblastoma patients","volume":"2","author":"Welch","year":"2013","journal-title":"CNS Oncol"},{"issue":"Supplement_1","key":"10.1016\/j.wneu.2024.01.006_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1227\/neu.0000000000002375_867","article-title":"867 postoperative metformin is associated with improved survival of glioblastoma patients","volume":"69","author":"Mohammad","year":"2023","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2024.01.006_bib28","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ijc.32337","article-title":"Use of metformin and outcome of patients with newly diagnosed glioblastoma: pooled analysis","volume":"146","author":"Seliger","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.wneu.2024.01.006_bib29","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11060-021-03786-8","article-title":"A\u00a0Phase I clinical trial of dose-escalated metabolic therapy combined with concomitant radiation therapy in high-grade glioma","volume":"153","author":"Porper","year":"2021","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2024.01.006_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104484","article-title":"Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence","volume":"90","author":"Fuentes-Fayos","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.wneu.2024.01.006_bib31","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s00066-015-0884-5","article-title":"Metformin influences progression in diabetic glioblastoma patients","volume":"191","author":"Adeberg","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.wneu.2024.01.006_bib32","first-page":"887","article-title":"Effect of metformin on cell proliferation, apoptosis, migration and invasion in A172 glioma cells and its mechanisms","volume":"20","author":"Xiong","year":"2019","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.wneu.2024.01.006_bib33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK - a nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.wneu.2024.01.006_bib34","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.wneu.2024.01.006_bib35","doi-asserted-by":"crossref","first-page":"501","DOI":"10.33549\/physiolres.934618","article-title":"The role of AMPK\/mTOR signaling pathway in anticancer activity of metformin","volume":"70","author":"Chomanicova","year":"2021","journal-title":"Physiol Res"},{"key":"10.1016\/j.wneu.2024.01.006_bib36","doi-asserted-by":"crossref","first-page":"8250","DOI":"10.18632\/oncotarget.14159","article-title":"Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation","volume":"8","author":"Leidgens","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.wneu.2024.01.006_bib37","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/cancers12010210","article-title":"Metformin as potential therapy for high-grade glioma","volume":"12","author":"Mazurek","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.wneu.2024.01.006_bib38","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"Hay","year":"2004","journal-title":"Genes Dev"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875024000160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875024000160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:53:37Z","timestamp":1749689617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875024000160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":36,"alternative-id":["S1878875024000160"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2024.01.006","relation":{},"ISSN":["1878-8750"],"issn-type":[{"type":"print","value":"1878-8750"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival Impact of Combined Biguanide and Temozolomide in Glioblastoma Preclinical Models: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2024.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}